|

Rivastigmine Transdermal Product Clinical Trials

1 actively recruiting trial

Pipeline

Phase 4: 1

Top Sponsors

  • UMC Utrecht1

Indications

  • Depressive Disorder1
  • Depression1

Other1 trial

Prediction of ECT Treatment Response and Reduction of Cognitive Side-effects Using EEG and Rivastigmine
Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.